Elevated CRP levels might represent high level of PD-L1 expression in malignancies including soft tissue sarcomas, thus CRP might have a role to serve as an indicator for immune checkpoint blockade therapy with anti-PD-1 antibodies. The gene discussed is CD274; the disease is soft tissue sarcoma.